Pharmaceuticals and Healthcare Reports Visceral Pain Market | Page 2

- The report summarizes all the dormant and discontinued pipeline projects- The report reviews latest news related to pipeline therapeutics for Visceral Pain
Reasons To Buy- Gain strategically significant competitor information, analysis, and insights to formulate effective R & D strategies- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage- Identify and understand important and diverse types of therapeutics under development for Visceral Pain- Identify potential new clients or partners in the target demographic- Develop strategic initiatives by understanding the focus areas of leading companies- Plan mergers and acquisitions effectively by identifying key players and it ' s most promising pipeline therapeutics- Devise corrective measures for pipeline projects by understanding Visceral Pain pipeline depth and focus of Indication therapeutics- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope- Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline
Buy a Sample Copy of This Report @ http:// www. radiantinsights. com / research / visceral-pain-pipeline-reviewh2-2016 / request-sample
Table of Contents Table of Contents 2 List of Tables 5 List of Figures 5 Introduction 6 Global Markets Direct Report Coverage 6 Visceral Pain Overview 7 Therapeutics Development 8 Pipeline Products for Visceral Pain- Overview 8 Pipeline Products for Visceral Pain- Comparative Analysis 9 Visceral Pain- Therapeutics under Development by Companies 10 Visceral Pain- Therapeutics under Investigation by Universities / Institutes 11 Visceral Pain- Pipeline Products Glance 12 Clinical Stage Products 12 Early Stage Products 13 Visceral Pain- Products under Development by Companies 14 Visceral Pain- Products under Investigation by Universities / Institutes 15 Visceral Pain- Companies Involved in Therapeutics Development 16 Addex Therapeutics Ltd 16 Astellas Pharma Inc. 17 Chromocell Corporation 18 GIcare Pharma Inc 19 Grunenthal GmbH 20 Medestea Research & Production S. p. A. 21 Neurim Pharmaceuticals Ltd 22 Pfizer Inc. 23 Visceral Pain- Therapeutics Assessment 24 Assessment by Monotherapy Products 24 Assessment by Target 25 Assessment by Mechanism of Action 27 Assessment by Route of Administration 29 Assessment by Molecule Type 30